Please provide your email address to receive an email when new articles are posted on . Until recently, orthopedic surgeons lacked specialty-specific recommendations for preventing venous ...

New evidence-based guidelines from the American College of Chest Physicians (ACCP) recommend considering individual patients' risk of thrombosis when deciding for or against the use of preventive ...

The post-operative risk period for venous thromboembolism is still unknown and indications for post-discharge prophylaxis are controversial. Detectable thrombus formation after hip arthroplasty is ...

Venous thromboembolism, though rare in the community, is a major cause of death among hospitalized patients. It is estimated to cause 100,000 deaths per year and to contribute to mortality in another ...

Functional impairment (FI) after hematopoietic cell transplantation (HCT) and impact on quality of life (QOL). Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind ...

antithrombin III [human] Thrombate III inj Hereditary antithrombin III (AT-III) deficiency in surgical or obstetrical procedures and thromboembolism Infuse over 10–20mins. Dose (units required) = ...

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the ...

Please provide your email address to receive an email when new articles are posted on . While I am a firm believer that aspirin is effective for the majority of our patients as a form of DVT and ...

“DVT, which may lead to PE, is a serious medical condition,” said Richard J. Friedman, M.D., FRCSC, professor of orthopaedic surgery, Medical University of South Carolina. “The FDA approval of Eliquis ...